SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Norwest Venture Partners IX, LP

(Last) (First) (Middle)
525 UNIVERSITY AVENUE, SUITE 800

(Street)
PALO ALTO CA 94301

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Apigee Corp [ APIC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
04/29/2015
4. If Amendment, Date of Original Filed (Month/Day/Year)
05/01/2015
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 04/29/2015 C 4,976,891 A (2)(3)(4)(5)(6)(7)(8)(9) 4,976,891 D
Common Stock 04/29/2015 C 873,561 A (2)(3)(4)(5)(6)(7)(8)(9) 873,561 I By Limited Partnership(10)
Common Stock 04/29/2015 C 423,812 A (8) 423,812 I By Limited Partnership(11)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Convertible Preferred Stock(2) (2) 04/29/2015 C 719,441 (2) (2) Common Stock(1) 907,306 $0.00 0 D
Series B Convertible Preferred Stock(3) (3) 04/29/2015 C 492,945 (3) (3) Common Stock(1) 671,982 $0.00 0 D
Series C Convertible Preferred Stock(4) (4) 04/29/2015 C 936,231 (4) (4) Common Stock(1) 936,231 $0.00 0 D
Series D Convertible Preferred Stock(5) (5) 04/29/2015 C 570,623 (5) (5) Common Stock(1) 570,623 $0.00 0 D
Series E Convertible Preferred Stock(6) (6) 04/29/2015 C 578,462 (6) (6) Common Stock(1) 578,462 $0.00 0 D
Series F Convertible Preferred Stock(7) (7) 04/29/2015 C 468,039 (7) (7) Common Stock(1) 468,039 $0.00 0 D
Series G Convertible Preferred Stock(8) (8) 04/29/2015 C 503,059 (8) (8) Common Stock(1) 503,059 $0.00 0 D
Series H Convertible Preferred Stock(9) (9) 04/29/2015 C 329,172 (9) (9) Common Stock(1) 341,189 $0.00 0 D
Series A Convertible Preferred Stock(2) (2) 04/29/2015 C 124,283 (2) (2) Common Stock 156,736 $0.00 0 I By Limited Partnership(10)
Series B Convertible Preferred Stock(3) (3) 04/29/2015 C 85,156 (3) (3) Common Stock 116,084 $0.00 0 I By Limited Partnership(10)
Series C Convertible Preferred Stock(4) (4) 04/29/2015 C 161,733 (4) (4) Common Stock 161,733 $0.00 0 I By Limited Partnership(10)
Series D Convertible Preferred Stock(5) (5) 04/29/2015 C 103,472 (5) (5) Common Stock 103,472 $0.00 0 I By Limited Partnership(10)
Series E Convertible Preferred Stock(6) (6) 04/29/2015 C 104,894 (6) (6) Common Stock 104,894 $0.00 0 I By Limited Partnership(10)
Series F Convertible Preferred Stock(7) (7) 04/29/2015 C 82,113 (7) (7) Common Stock 82,113 $0.00 0 I By Limited Partnership(10)
Series G Convertible Preferred Stock(8) (8) 04/29/2015 C 88,320 (8) (8) Common Stock 88,320 $0.00 0 I By Limited Partnership(10)
Series H Convertible Preferred Stock(9) (9) 04/29/2015 C 58,088 (9) (9) Common Stock 60,209 $0.00 0 I By Limited Partnership(10)
Series G Convertible Preferred Stock(8) (8) 04/29/2015 C 423,812 (8) (8) Common Stock 423,812 $0.00 0 I By Limited Partnership(11)
1. Name and Address of Reporting Person*
Norwest Venture Partners IX, LP

(Last) (First) (Middle)
525 UNIVERSITY AVENUE, SUITE 800

(Street)
PALO ALTO CA 94301

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Crowe Jeffrey

(Last) (First) (Middle)
525 UNIVERSITY AVENUE, SUITE 800

(Street)
PALO ALTO CA 94301

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Howard Matthew D.

(Last) (First) (Middle)
525 UNIVERSITY AVENUE, SUITE 800

(Street)
PALO ALTO CA 94301

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
NORWEST VENTURE PARTNERS VIII LP

(Last) (First) (Middle)
525 UNIVERSITY AVENUE, SUITE 800

(Street)
PALO ALTO CA 94301

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Norwest Venture Partners XI, LP

(Last) (First) (Middle)
525 UNIVERSITY AVENUE, SUITE 800

(Street)
PALO ALTO CA 94301

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. The securities shown on Line 1 of Table 1 and Lines 1 through 8 of Table 2 represent securities held of record by Norwest Venture Partners IX, LP ("NVP IX"). By virtue of their positions as co-Chief Executive Officers of NVP Associates, LLC ("NVP Associates"), the managing member of the general partner of NVP IX, Matthew Howard and Jeffrey Crowe may be deemed to share voting and dispositive power with respect to such securities. Messrs. Howard and Crowe disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein.
2. The Series A Convertible Preferred Stock automatically converted into Common Stock on a 1.261 for one basis immediately prior to completion of the Issuer's initial public offering of common stock and had no expiration date.
3. The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1.363 for one basis immediately prior to completion of the Issuer's initial public offering of common stock and had no expiration date.
4. The Series C Convertible Preferred Stock automatically converted into Common Stock on a one for one basis immediately prior to completion of the Issuer's initial public offering of common stock and had no expiration date.
5. The Series D Convertible Preferred Stock automatically converted into Common Stock on a one for one basis immediately prior to completion of the Issuer's initial public offering of common stock and had no expiration date.
6. The Series E Convertible Preferred Stock automatically converted into Common Stock on a one for one basis immediately prior to completion of the Issuer's initial public offering of common stock and had no expiration date.
7. The Series F Convertible Preferred Stock automatically converted into Common Stock on a one for one basis immediately prior to completion of the Issuer's initial public offering of common stock and had no expiration date.
8. The Series G Convertible Preferred Stock automatically converted into Common Stock on a one for one basis immediately prior to completion of the Issuer's initial public offering of common stock and had no expiration date.
9. The Series H Convertible Preferred Stock automatically converted into Common Stock on a 1.037 for one basis immediately prior to completion of the Issuer's initial public offering of common stock and had no expiration date.
10. The securities shown on Line 2 of Table 1 and Lines 9 through 16 of Table 2 represent securities held of record by Norwest Venture Partners VIII, LP ("NVP VIII"). By virtue of their positions as co-Chief Executive Officers of NVP Associates, LLC ("NVP Associates"), the managing member of the general partner of NVP VIII, Matthew Howard and Jeffrey Crowe may be deemed to share voting and dispositive power with respect to such securities. Messrs. Howard and Crowe disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein.
11. The securities shown on Line 3 of Table 1 and Line 17 of Table 2 represent securities held of record by Norwest Venture Partners XI, LP ("NVP XI"). By virtue of their positions as co-Chief Executive Officers of NVP Associates, LLC ("NVP Associates"), the managing member of the general partner of NVP XI, Matthew Howard and Jeffrey Crowe may be deemed to share voting and dispositive power with respect to such securities. Messrs. Howard and Crowe disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein.
Remarks:
By: /s/ Kurt Betcher, as Attorney-in-fact 05/01/2015
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.